Most recently, it has been discovered that conolidine and the above mentioned derivatives act over the atypical chemokine receptor three (ACKR3. Expressed in identical parts as classical opioid receptors, it binds to a wide array of endogenous opioids. Unlike most opioid receptors, this receptor